男性乳腺发育症发病率显著增加:1998至2017年一项20年国家登记研究
该研究基于丹麦国家患者登记系统,纳入1998至2017年所有0-80岁首次诊断为男性乳腺发育症的丹麦男性,评估年龄相关发病率和长期趋势。20年间共登记17601例,平均20年发病率为3.4/10000男性,青春期后16-20岁男性年均发病率为6.5/10000,61-80岁男性为4.6/10000,两个年龄组分别增加5倍和11倍。结论认为男性乳腺发育症发病率在过去20年急剧增加。
要点
- 20年研究期间共登记17601例男性乳腺发育症,平均每年880例新发病例。
- 0-80岁男性平均20年发病率为3.4/10000。
- 16-20岁男性年均发病率为6.5/10000,61-80岁男性为4.6/10000,分别增加5倍和11倍。
核心结论
- 男性乳腺发育症发病率在过去20年急剧增加,提示内源性或外源性性类固醇环境发生变化,并与男性前列腺癌、代谢综合征、2型糖尿病或心血管疾病等不良健康结局风险增加相关。
研究设计与样本
- 观察性、20年国家登记研究,使用丹麦全国登记数据,纳入1998至2017年所有0-80岁首次诊断为男性乳腺发育症的丹麦男性。
主要发现
- 20年研究期间共17601例男性(0-80岁)登记首次诊断男性乳腺发育症,相当于每年880例新发病例,平均20年发病率为3.4/10000男性(0-80岁)。
- 16-20岁青春期后男性平均年发病率为6.5/10000,61-80岁男性为4.6/10000。
- 上述两个年龄组在20年期间分别总体增加5倍和11倍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Gynecomastia, the proliferation of mammary glandular tissue in the male, is a frequent but little-studied condition. Available prevalence data are based on selected patient populations or autopsy cases with their inherent bias. OBJECTIVE: The objective of this work is to evaluate the age-related incidence and secular trends in gynecomastia in the general population. DESIGN: An observational, 20-year national registry study was conducted. SETTING: This population-based study used nationwide registry data. PARTICIPANTS: Participants included all Danish males (age 0-80 years) with a first-time diagnosis of gynecomastia. MAIN OUTCOME MEASURES: All Danish males (age 0-80 years) were followed up for incident diagnosis of gynecomastia in the Danish National Patient Registry from 1998 to 2017 using the International Codes of Diseases, 10th revision, and the Danish Health Care Classification System. Age-specific incidence rates were estimated. The hypothesis tested in this study was formulated prior to data collection. RESULTS: Overall, a total 17 601 males (age 0-80 years) were registered with an incident diagnosis of gynecomastia within the 20-year study period, corresponding to 880 new cases per year and an average 20-year incidence of 3.4 per 10 000 men (age 0-80 years). The average annual incidence was 6.5/10 000 in postpubertal males age 16 to 20 years and 4.6/10 000 in males age 61 to 80 years, with a respective 5- and 11-fold overall increase in these 2 age groups over the 20-year period. CONCLUSIONS: The incidence of gynecomastia has dramatically increased over the last 20 years, implying that the endogenous or exogenous sex-steroid environment has changed, which is associated with other adverse health consequences in men such as an increased risk of prostate cancer, metabolic syndrome, type 2 diabetes, or cardiovascular disorders.
引用
- Koch T, Bräuner EV, Busch AS, et al. Marked Increase in Incident Gynecomastia: A 20-Year National Registry Study, 1998 to 2017. J Clin Endocrinol Metab. 2020. PMID: 32754750. doi:10.1210/clinem/dgaa440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。